A Case of Cystic Fibrosis With a Rare Mutation (3849 + 10 kbC > T) and Normal Sweat Chloride Levels

authors:

avatar Taha Resid Ozdemir 1 , * , avatar Ali Kanik 2

Genetic Diagnostic Center, Izmir Tepecik Training and Research Hospital, Izmir, Turkey
Izmir Tepecik Training and Research Hospital, Izmir, Turkey

how to cite: Ozdemir T R, Kanik A. A Case of Cystic Fibrosis With a Rare Mutation (3849 + 10 kbC > T) and Normal Sweat Chloride Levels. Iran J Pediatr. 2015;25(2):e369. https://doi.org/10.5812/ijp.369.

References

  • 1.

    Egan M. Cystic fibrosis. In: Kliegman RM, Stanton B. F, Geme JS, Schor NF, Behrman RE, editors. Nelson Textbook of Pediatrics. USA: Judith Fletcher; 2011. p. 1481-97. https://doi.org/10.1016/B978-1-4377-0755-7.00395-X.

  • 2.

    Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994;331(15):974-80. [PubMed ID: 7521937]. https://doi.org/10.1056/NEJM199410133311503.

  • 3.

    Feldmann D, Couderc R, Audrezet MP, Ferec C, Bienvenu T, Desgeorges M, et al. CFTR genotypes in patients with normal or borderline sweat chloride levels. Hum Mutat. 2003;22(4):340. [PubMed ID: 12955726]. https://doi.org/10.1002/humu.9183.

  • 4.

    Augarten A, Yahav Y, Szeinberg A, Noiman S, Gazit E, Kerem BS, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C; T mutation. Lancet. 1993;342(8862):25-6.

  • 5.

    Stern RC, Doershuk CF, Drumm ML. 3849+10kbC>T mutation and disease severity in cystic fibrosis. Lancet J. 1995;346(8970):274-6.

  • 6.

    Gilbert F, Li Z, Arzimanoglou II, Bialer M, Denning C, Gorvoy J. Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849+10kbC>T: significance for geneticists. Am J Med Genet. 1995;58(4):356-9.

  • 7.

    Dugueperoux I, De Braekeleer M. The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype. Eur Respir J. 2005;25(3):468-73. [PubMed ID: 15738290]. https://doi.org/10.1183/09031936.05.10100004.

  • 8.

    Liu LC, Shyur SD, Chu SH, Huang LH, Kao YH, Lei WT. Cystic fibrosis: experience in one institution. J Microbiol Immunol Infect. 2014;47(4):358-61.

  • 9.

    Halicioglu O, Akman SA, Sutcuoglu S, Coker I. Diverse genotypical features and impacts on clinical course and severity of cystic fibrosis: early childhood experience. Minerva Pediatr. 2011;63(3):169-75. [PubMed ID: 21654597].

  • 10.

    Yilmaz E, Erdem H, Ozguc M, Coskun T, Ozcelik U, Gocmen A, et al. Study of 12 mutations in Turkish cystic fibrosis patients. Hum Hered. 1995;45(3):175-7. [PubMed ID: 7542223].